CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


SARS-CoV-2 IgG Antibody Testing KitWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug364 Hydroxychloroquine + azithromycin Wiki 0.71
drug360 Hydroxychloroquine Wiki 0.13

Correlated MeSH Terms (5)


Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.17
D011014 Pneumonia NIH 0.08
D007239 Infection NIH 0.08
D045169 Severe Acute Respiratory Syndrome NIH 0.07
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers and Candidacy for Convalescent Plasma Therapy/Prophylaxis

The purpose of this study is to validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers. Additionally, we would like to evaluate the incidence of seroconversion in this high-risk population and to identify possible candidates for convalescent plasma donation for therapy/prophylaxis.

NCT04334876 SARS-CoV-2 Diagnostic Test: SARS-CoV-2 IgG Antibody Testing Kit

Primary Outcomes

Description: To validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers

Measure: Validation of SARS-CoV-2 IgG Antibody Test

Time: April 2020-January 2021

Secondary Outcomes

Description: To evaluate the incidence of seroconversion in this high-risk population

Measure: Incidence of Seroconversion

Time: April 2020-January 2021

Description: To identify possible candidates for convalescent plasma donation for therapy/prophylaxis (https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-inds)

Measure: Identify Candidacy

Time: April 2020-January 2021


No related HPO nodes (Using clinical trials)